LIBIPHARM

LIBI PHARM is a pioneering, privately owned Israeli drug and medical device development company that has created the patented, innovative product Virlaza®️, which could be a breakthrough in the treatment of a number of diseases characterized by acute respiratory failure, including those caused by the COVID-19 coronavirus, as well as a number of immunological disorders... LibiPharm | Global solutions in pulmonology, immunology and virology

Also known as: LibiPharm LLC